Marathon Pharmaceuticals, LLC today announced Dave Bradshaw has joined the company as executive director of manufacturing. In this role, Bradshaw will oversee the manufacturing and supply operations for Marathon Pharmaceuticals’ rapidly growing portfolio of treatments.
(Reuters) – Swiss drugmaker Novartis AG does not expect copycat versions of biotech drugs to play an important role in the healthcare system for another three to five years, its chief executive said on Monday.
The logic behind the Sunshine Act says that providing clarity on any money that pharma and device makers pay to doctors and hospitals will reduce the occurrence or appearance of corruption. .
The idea is that by making those payments a matter of public record makes it undesirable for companies to try to influence medical experts.
Eli Lilly and Company’s (NYSE: LLY) investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.
WASHINGTON (AP) — Ending insurance discrimination against the sick was a central goal of the nation’s health care overhaul, but leading patient groups say that promise is being undermined by new barriers from insurers.
AbbVie yesterday announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program. Voting for two of the 40 winners to earn the title of 2014 Thriving Undergraduate or Graduate Scholar is now open to the public at www.AbbVieCFScholarship.com until September 15.